Telix Pharmaceuticals Limited is a biopharmaceutical company headquartered in Melbourne, Australia, with operations in the US, Europe, and Japan. The company specializes in developing therapeutic and diagnostic radiopharmaceuticals, targeting significant unmet needs in oncology and rare diseases. Telix's key value propositions include its focus on theranostics, molecularly targeted radiation, and advanced imaging technologies, positioning it as a leader in the field of nuclear medicine.
Telix Pharmaceuticals is a rapidly growing radiopharmaceutical company seeking a Global Clinical Lead to support the international rollout of a novel prostate cancer imaging agent. This role involves clinical strategy development, cross-functional collaboration, and ensuring regulatory compliance and data integrity. The ideal candidate will be data-driven, collaborative, and focused on improving patient outcomes in oncology and rare diseases. They will partner with global program leads, medical affairs, regulatory, manufacturing and commercial teams to navigate clinical development challenges.
Telix Pharmaceuticals Limited is a biopharmaceutical company headquartered in Melbourne, Australia, with operations in the US, Europe, and Japan. The company specializes in developing therapeutic and diagnostic radiopharmaceuticals, targeting significant unmet needs in oncology and rare diseases. Telix's key value propositions include its focus on theranostics, molecularly targeted radiation, and advanced imaging technologies, positioning it as a leader in the field of nuclear medicine.
Telix Pharmaceuticals Limited